pharma

Version 5.0 of the software features tools for normalizing concepts such as gene mutations and additional query features for mining text documents.

The launch follows a beta that kicked off earlier this year to put the software through its paces with data curators and other scientists.

The resource will offer easy access to an inventory of vendors with patient-derived xenograph models as well as associated molecular data for oncology drug discovery projects.

The custom software development company will soon test a tool called 5AM Sunrise for managing and aggregating clinical and molecular data.

The company is working on a bespoke pharmacovigilance product that will leverage its biomedical content, and has added an NGS module to Pathway Studio. 

The company will use some of the funds to set up a new research laboratory within the US to better support collaborations with pharma and biotech.

Lonza now offers kits and services featuring Roche's MycoTool detection kits for final release testing of pharmaceutical products, upon validation. In the meantime, Lonza continues to develop its own pharma QC products, including mycoplasma detection assays, on BD's automated testing platform.

BD Diagnostics and Switzerland's Lonza have inked an agreement to develop and commercialize Lonza's microCompass molecular assays on the BD Max system for pharmaceutical quality-control testing.

HCP and BioMed Realty, two of the nation's largest publicly-traded owners of life sciences space, offered largely upbeat updates on their businesses this week following the release of their quarterly financial results.

BioEnterprise's Midwest Health Care Venture Investment Report showed a total 47 companies raising a combined $155.6 million during the first quarter of 2009, compared with 14 companies winning $133.5 million in the year-ago period.

Pages

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.